Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SoBe

This article was originally published in The Tan Sheet

Executive Summary

PepsiCo acquires majority stake in functional drinks marketer South Beach Beverage, firms announce. Purchase, N.Y.-based company co-founder and CEO John Bello holds onto equity stake as part of deal. South Beach received FDA warning letter earlier this year for claims on its drinks containing herbal ingredients (1"The Tan Sheet" July 31, p. 8)

You may also be interested in...



State AGs Pick Up Enforcement Slack Amid Expanding Products And Claims

State agencies are taking a bigger role in labeling enforcement actions, driven by the proliferation of dietary supplement and food companies that make health claims for their products, say officials from the Connecticut and Texas attorneys general offices

State AGs Pick Up Enforcement Slack Amid Expanding Products And Claims

State agencies are taking a bigger role in labeling enforcement actions, driven by the proliferation of dietary supplement and food companies that make health claims for their products, say officials from the Connecticut and Texas attorneys general offices

State AGs Pick Up Enforcement Slack Amid Expanding Products And Claims

State agencies are taking a bigger role in labeling enforcement actions, driven by the proliferation of dietary supplement and food companies that make health claims for their products, say officials from the Connecticut and Texas attorneys general offices

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091894

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel